These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38936477)

  • 1. Contributions of the qualitative Qualicor study embedded in a cohort study on the circumstances of SARS-CoV 2 infection in France.
    Perrey C; Mailles A; Septfons A; Charmet T; Cheny O; Von Platen C; Huet P; Lévy-Bruhl D; Galmiche S; Fontanet A; Jauffret-Roustide M
    Infect Dis Now; 2024 Jun; ():104943. PubMed ID: 38936477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Source of SARS-CoV-2 infection: results from a series of 584,846 cases in France from October 2020 to August 2022.
    Rakover A; Galmiche S; Charmet T; Chény O; Omar F; David C; Martin S; Mailles A; Fontanet A
    BMC Public Health; 2024 Jan; 24(1):325. PubMed ID: 38287286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study.
    Galmiche S; Cortier T; Charmet T; Schaeffer L; Chény O; von Platen C; Lévy A; Martin S; Omar F; David C; Mailles A; Carrat F; Cauchemez S; Fontanet A
    Lancet Microbe; 2023 Jun; 4(6):e409-e417. PubMed ID: 37084751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
    Santiago-Delefosse M; Cahen F; Coeffin-Driol C
    Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir for the treatment of COVID-19.
    Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study.
    Denis F; Septans AL; Le Goff F; Jeanneau S; Lescure FX
    J Med Internet Res; 2021 May; 23(5):e26932. PubMed ID: 33878018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manifestation of Health Denialism in Attitudes toward COVID-19 Vaccination: A Qualitative Study.
    Młoźniak I; Zwierczyk U; Rzepecka E; Kobryn M; Wilk M; Duplaga M
    Vaccines (Basel); 2023 Dec; 11(12):. PubMed ID: 38140226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate risk perception for SARS-CoV-2 infection among Italian HCWs in the eve of COVID-19 pandemic.
    Riccò M; Vezzosi L; Balzarini F; Bragazzi NL
    Acta Biomed; 2020 May; 91(3):e2020040. PubMed ID: 32921735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early versus late tracheostomy in critically ill COVID-19 patients.
    Szafran A; Dahms K; Ansems K; Skoetz N; Monsef I; Breuer T; Benstoem C
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD015532. PubMed ID: 37982427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older Adults in the United States and COVID-19: A Qualitative Study of Perceptions, Finances, Coping, and Emotions.
    Goins RT; Anderson E; Minick H; Daniels H
    Front Public Health; 2021; 9():660536. PubMed ID: 34504824
    [No Abstract]   [Full Text] [Related]  

  • 19. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative study on safety perception among healthcare workers of a tertiary academic care center during the SARS-CoV-2 pandemic.
    Ehrenzeller S; Durovic A; Kuehl R; Martinez AE; Bielser M; Battegay M; von Rotz M; Fringer A; Tschudin-Sutter S
    Antimicrob Resist Infect Control; 2022 Feb; 11(1):30. PubMed ID: 35135617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.